These integrated findings were the (1) lack of prostate cancer resources for Black patients and their physicians, (2) perception among PCPs about the benefit of PSA testing, and (3) understanding of patient lived experiences and values by PCPs. The gene discussed is KLK3; the disease is prostate carcinoma.